Probing protein aggregation
02 July 2009
In 2006 an estimated 26.6 million people worldwide had Alzheimer's disease and those numbers are expected to have quadrupled by the year 2050. Now scientists in the US have developed a probe to better understand protein aggregation processes linked to the disease.
Songi Han at the University of California, Santa Barbara, and co-workers made the nitroxide-based molecule, which can be attached to specific amino acid sites in a protein.

The tau hypothesis proposes that tangles of tau proteins lead to Alzheimer's disease © National Institutes of Health (NIH) |
Han's team used the probe to follow tau protein aggregation on the molecular level. As Han explains, 'being able to measure interfacial and surface hydration dynamics provides us with a unique tool to map out interactions between species or the transport of protons and water across membranes.' Introducing the probe into amyloid fibre proteins, such as those formed by tangled tau proteins, could give a clearer picture of how the fibres form and lead to further insight into the proteins' structural characteristics.
- Mark Wilson
Paul Cooper
Enjoy this story? Spread the word using the 'tools' menu on the left or add a comment to the Chemistry World blog.
Link to journal article
Site-specific dynamic nuclear polarization of hydration water as a generally applicable approach to monitor protein aggregation
Anna Pavlova, Evan R. McCarney, Dylan W. Peterson, Frederick W. Dahlquist, John Lew and Songi Han, Phys. Chem. Chem. Phys., 2009, 11, 6833
DOI: 10.1039/b906101k
Also of interest
Instant insight: Think outside the cell
Mark Wilson and Justin Yerbury at the University of Wollongong, Australia, examine proteins' extracellular activities.
Fresh hope in battling Alzheimer's disease with three-pronged attack
The chemistry of Alzheimer
s disease
Arvi Rauk, Chem. Soc. Rev., 2009, 38, 2698
DOI: 10.1039/b807980n
O-GlcNAc modification in diabetes and Alzheimer's disease
Wagner B. Dias and Gerald W. Hart, Mol. BioSyst., 2007, 3, 766
DOI: 10.1039/b704905f
Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid
-peptide
Rukhsana Sultana and D. Allan Butterfield, Mol. BioSyst., 2008, 4, 36
DOI: 10.1039/b715278g
Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer
s disease
Laura Bica, Peter J. Crouch, Roberto Cappai and Anthony R. White, Mol. BioSyst., 2009, 5, 134
DOI: 10.1039/b816577g
Targeting neurological disease with RNAi
Paul Lingor and Mathias Bähr, Mol. BioSyst., 2007, 3, 773
DOI: 10.1039/b701169e
